enrofloxacin has been researched along with Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbon, CM; Cole, G; D'Andrea, A; Gallington, LC; Guinan, EC; Kalish, LA; Kutok, J; Levy, O; Mancuso, CJ; Palmer, CD; Parmar, K; Russell, JD; Soiffer, R; Stoler-Barak, L; Suter, EE; Vergilio, JA; Voskertchian, A; Weiss, JP; Zhu, K | 1 |
| McClure, JT; Meinen, JB; Rosin, E | 1 |
1 trial(s) available for enrofloxacin and Neutropenia
| Article | Year |
|---|---|
Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death.
Topics: Ablation Techniques; Animals; Antimicrobial Cationic Peptides; Blood Cell Count; Blood Proteins; Bone Marrow; Cytokines; Endotoxemia; Endotoxins; Enrofloxacin; Fluoroquinolones; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Inflammation Mediators; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Neutropenia; Organ Size; Radiation Injuries; Survival Analysis; Whole-Body Irradiation | 2011 |
1 other study(ies) available for enrofloxacin and Neutropenia
| Article | Year |
|---|---|
Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections.
Topics: Animals; Anti-Infective Agents; Biotransformation; Cyclophosphamide; Dogs; Dose-Response Relationship, Drug; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Male; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Neutropenia; Quinolones; Species Specificity; Staphylococcal Infections | 1995 |